Jenburkt Pharma Re-appoints Dilip H. Bhuta as Whole Time Director & CFO for 5 Years

Jenburkt Pharmaceuticals Ltd announced the re-appointment of Shri. Dilip H. Bhuta as Whole Time Director and Chief Financial Officer (CFO) for a term of five years, effective April 1, 2027, to March 31, 2032. The shareholders approved this re-appointment at the 41st Annual General Meeting (AGM). The company also secured approval for remuneration payment for a three-year period from April 1, 2027, to March 31, 2030. Shri. Bhuta, aged 74, has been with the company since 2013 and brings extensive banking experience.